Europe Idiopathic Pulmonary Fibrosis Treatment Market
Europe Idiopathic Pulmonary Fibrosis Treatment Market Report by Drug Class (MAPK Inhibitors, Tyrosine Inhibitors, Autotaxin Inhibitors), End User (Hospitals, Long-term Care Facilities, and Others), and Country 2025-2033
The Europe idiopathic pulmonary fibrosis treatment market size reached US$ 598.9 Million in 2024. Looking forward, IMARC Group expects the market to reach US$ 1,145.4 Million by 2033, exhibiting a growth rate (CAGR) of 7.47% during 2025-2033.
Report Attribute
Key Statistics
Base Year
2024
Forecast Years
2025-2033
Historical Years
2019-2024
Market Size in 2024
US$ 598.9 Million
Market Forecast in 2033
US$ 1,145.4 Million
Market Growth Rate 2025-2033
7.47%
Idiopathic pulmonary fibrosis (IPF) is a persistent lung infection that causes scarring of the lungs. This hampers the oxygen-carrying functionality of the organ, thereby resulting in breathing difficulties. Some of the common symptoms include a persistent dry cough, fatigue, loss of appetite, and swollen limbs. IPF is diagnosed through blood tests, chest X-ray, computer tomography (CT) scan, lung biopsy, and pulmonary function tests. It can be treated by prescribing anti-fibrotic drugs and supportive treatment options, such as oxygen therapy and palliative care.
Europe Idiopathic Pulmonary Fibrosis Treatment Market Trends:
The Europe IPF treatment market is primarily being driven by the increasing prevalence of chronic lung and fibrotic diseases, especially in the geriatric population. This can be attributed to changing living standards, high smoking rates, and increasing environment pollutants. Other than this, increasing health consciousness amongst consumers and rising awareness regarding the presence of effective IPF preventive and management strategies are catalyzing the market growth. In line with this, increasing government expenditures for the development of existing healthcare systems and rapid advancements in diagnostic techniques are acting as another growth-inducing factor. The implementation of favorable regulatory policies and continuous investments in research and development (R&D) activities for introducing novel medicines are further creating a positive outlook for the market in the region.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the Europe idiopathic pulmonary fibrosis treatment market report, along with forecasts at the regional and country level from 2025-2033. Our report has categorized the market based on drug class and end user.
Breakup by Drug Class:
MAPK Inhibitors
Tyrosine Inhibitors
Autotaxin Inhibitors
Breakup by End User:
Hospitals
Long-term Care Facilities
Others
Breakup by Country:
Germany
France
United Kingdom
Italy
Spain
Others
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
Report Coverage:
Report Features
Details
Base Year of the Analysis
2024
Historical Period
2019-2024
Forecast Period
2025-2033
Units
US$ Million
Segment Coverage
Drug Class, End User, Country
Countries Covered
Germany, France, United Kingdom, Italy, Spain, Others
Customization Scope
10% Free Customization
Report Price and Purchase Option
Single User License: US$ 3699
Five User License: US$ 4699
Corporate License: US$ 5699
Post-Sale Analyst Support
10-12 Weeks
Delivery Format
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
Key Questions Answered in This Report
The Europe idiopathic pulmonary fibrosis treatment market was valued at US$ 598.9 Million in 2023.
We expect the Europe idiopathic pulmonary fibrosis treatment market to exhibit a CAGR of 7.47% during 2024-2032.
The rising prevalence of chronic lung and fibrotic diseases, along with the growing consumer awareness regarding the presence of effective idiopathic pulmonary fibrosis preventive and management treatment, is primarily driving the Europe idiopathic pulmonary fibrosis treatment market.
The sudden outbreak of the COVID-19 pandemic had led to the postponement of elective idiopathic pulmonary fibrosis treatment procedures to reduce the risk of the coronavirus infection upon hospital visits and interaction with healthcare professionals or medical equipment.
Based on the drug class, the Europe idiopathic pulmonary fibrosis treatment market has been bifurcated into MAPK inhibitors, tyrosine inhibitors, and autotaxin inhibitors. Among these, tyrosine inhibitors currently hold the majority of the total market share.
Based on the end user, the Europe idiopathic pulmonary fibrosis treatment market can be segmented into hospitals, long-term care facilities, and others. Currently, hospitals exhibit a clear dominance in the market.
On a regional level, the market has been classified into Germany, France, United Kingdom, Italy, Spain, and others.
Need more help?
Speak to our experienced analysts for insights on the current market scenarios.
Include additional segments and countries to customize the report as per your requirement.
Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
For further assistance, please connect with our analysts.
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-631-791-1145
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-714-6104
Email: sales@imarcgroup.com
Client Testimonials
IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.
The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required
We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra
We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.
The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.
The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.
My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.
I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.
We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.
IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.
IMARC did an outstanding job in preparing our study. They were punctual and precise, delivering all the data we required in a clear and well-organized format. Their attention to detail and ability to meet deadlines was impressive, making them a reliable partner for our project.
I wanted to express my sincere appreciation for your efforts in handling this matter. Your dedication and commitment have truly been commendable. It is evident that you have put in a tremendous amount of hard work and expertise into resolving the issues at hand.
I would also like to take this opportunity to inform you that we are greatly interested
Overall, the deliverable was well organized and my experience with the project team was good. In particular, I appreciated how they responded when I requested additional information and the Japanese version.
The IMARC team were extremely professional and very cooperative. The team were also extremely flexible in making changes and modifications wherever required. The entire experience right from project kick-off to after sales support was fruitful and smooth.
I’d like to express my gratitude for the work you accomplished with the industry report. The way you responded to the requirements and delivered under tight timelines shows your expertise, exceptional work ethic and commitment to your customer’s success. The entire team and company are incredibly thankful for your dedication. Once again, thank you
The market reports from IMARC have been instrumental in guiding our business strategies. We found the reports comprehensive and data-driven, which helped us make informed decisions. The detailed insights and actionable data have consistently provided us with a competitive edge in a rapidly changing alcohol market.
One of the best things about IMARC is their flexibility and predisposition to tailor the reports and adapt to our needs. They are not just great in their researching and consulting solutions, but their service is unparallelled. We’ve worked with them a couple of times and we will keep working with them in future projects.
We recently commissioned multiple market research reports from IMARC, and the insights we received were invaluable. The depth of analysis, accuracy of data, and actionable recommendations have greatly enhanced our strategic decision-making.
The sale account manager and the service was excellent. The data and market trends gathered from the report was insightful and really assisted while planning future product and growth strategies.
Thank you very much for your cooperation and post purchase support. We were really happy with the final deliverable, and the takeaways from the report.